$FF

Biofuel Stock FutureFuel Corp. (NYSE: FF) Soars on Strong Second Quarter

FutureFuel Corp. (NYSE: FF) shares rose after it reported Q2 2026 results. The company said total revenue was $78.7 million, up 120.6% year over year, with GAAP net income of $11.4 million ($0.25 diluted) and adjusted EBITDA of $11.8 million. It also cited higher chemicals and biofuel revenue, improved production, and expects positive full-year 2026 adjusted EBITDA.

Original reporting
Published Aug 11, 2026, 6:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 6:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Biofuel Stock FutureFuel Corp. (NYSE: FF) Soars on Strong Second Quarter — source image
Decision brief

The 30-second read

$FFBullishMed
01

Why it matters

Traders can use the reported Q2 revenue, net income, Adjusted EBITDA, and the stated expectation for positive full-year 2026 Adjusted EBITDA to reassess near-term valuation and momentum. The mention of hedging and derivative timing effects is important for judging earnings quality and potential post-earnings volatility.

02

Market read

FF’s Q2 print shows a sharp turnaround to profitability and strong growth, with a forward-looking expectation for positive full-year Adjusted EBITDA, aligning with the stock’s large intraday gain.

03

What to watch

A more than three-week biodiesel plant outage occurred during Q2, and the article notes inability to quantify certain full-year Adjusted EBITDA reconciliation items, which can increase uncertainty around forward earnings quality.

Relevance 8/10Novelty 8/10Timing: after-hours/market session reaction to Q2 2026 earnings and guidance expectation

Background

The piece frames FutureFuel’s Q2 2026 performance across Chemicals and Biofuels, highlighting improved production economics, regulatory clarity, and balance-sheet optimization via tax credit monetization.

Company-level read

Ticker impact

$FFBullishMedium confidence
Context

FutureFuel reported Q2 2026 results with revenues up 120.6% and raised confidence in positive full-year 2026 Adjusted EBITDA.

Expected impact

Bullish bias for the next session(s), with volatility risk given heavy derivative/hedging timing effects and a biodiesel outage mentioned in the quarter.

Evidence & confidence

The article provides multiple concrete Q2 datapoints (revenue, net income, Adjusted EBITDA) and a forward-looking expectation for full-year 2026 Adjusted EBITDA, which are direct drivers for traders. However, it also flags timing benefits from biofuels hedging and derivative impacts, which can temper confidence in sustainability.

Market effects

Reinforces demand and regulatory tailwinds for domestic biofuel production, potentially supportive for renewable/biofuel peers’ sentiment.

Limited explicit regional spillover; focus is on US domestic production and tax credit monetization.

Mostly US policy and domestic production economics; limited direct global read-through beyond biofuel sentiment.

Counterpoint

The quarter’s gross profit and earnings improvement are partly driven by physical inventory sales above hedged levels and derivative timing effects, so the underlying run-rate may be less stable than headline profitability suggests.

Key entities

  • FutureFuel Corp.

    NYSE-listed biofuels and specialty chemicals manufacturer reporting Q2 2026 results and expecting positive full-year 2026 Adjusted EBITDA.

  • Roeland Polet

    Chairman and CEO quoted on profitability drivers, production economics, and full-year 2026 Adjusted EBITDA outlook.

  • Rose Sparks

    CFO quoted on cash flow, liquidity, and a four-year agreement to monetize Section 45Z credits.

Related articles

$FFMedAI 8/10

Why is FutureFuel stock surging today?

Investing.com reports FutureFuel Corp. shares rose 21.5% in pre-open trading after its Q2 2026 results. The company posted $78.7M revenue, up over 120% year over year, GAAP net income of $11.4M ($0.25/diluted share), and Adjusted EBITDA of $11.8M versus a $14.2M net loss in Q2 2025. Management cited stronger Chemicals demand and improved Biofuels regulation, reaffirming full-year 2026 guidance.

$FFMed

FutureFuel Corp. (FF): Results of Operations and Financial Condition

FutureFuel Corp. (FF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FUTUREFUEL ANNOUNCES SECOND QUARTER 2026 RESULTS BATESVILLE, Ark., August 10, 2026 – FutureFuel Corp . (NYSE: FF) (“FutureFuel” or the “Company”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the second quarte

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.

$AVGOMedAI 9/10

Broadcom’s AI Forecast Suggests Hyperscalers Want More Than Just Nvidia GPUs

Broadcom (AVGO) raised its AI chip revenue forecast to $115B for FY2027, up from $100B, and expects $230B in FY2028. This reflects Big Tech's demand for custom chips and networking components, reducing reliance on Nvidia (NVDA). KeyBanc reiterated an Overweight rating and $575 price target for AVGO. AVGO's Q3 revenue rose 86% YoY to $29.6B, but Q4 guidance was slightly below expectations. Hedge funds hold positions in both AVGO and NVDA, with Fisher Asset Management among the top holders.